News
Encephalitis – an invisible disability
24 October 2024
Every year, between 20-26th October, we celebrate Invisible Disability Week which was founded by the USA-based non profit organisation Invisible Disabilities Association (IDA) in 2014. The aim of this campaign is to promote awareness, education, and support for those living with an invisible disability and their families around the world. Global statistics on invisible disabilities […]
Read More
Researchers discover latest insights into after-effects of severe COVID-19 on the brain
26 September 2024
New steps have been taken towards a better understanding of the immediate and long-term impact of COVID-19 on the brain in the UK’s largest study to date. We are delighted to announce that a study from researchers led by the University of Liverpool (including our CEO Dr Ava Easton and members of our Scientific Advisory […]
Read More
Mpox and encephalitis
20 September 2024
Key points: Mpox, formerly known as monkeypox, can lead to rare but severe neurological complications. Encephalitis is the most common neurological complication of mpox infection, causing inflammation of the brain. Vaccination and early treatment are crucial in preventing severe outcomes of mpox infection. Introduction When you think about mpox (formerly known as monkeypox), you might […]
Read More
Oropouche virus – what you need to know
29 August 2024
A virus in Brazil has been causing concern for health organisations around the world. Introduction The Oropouche virus (pronounced o-ro-push) has now been described as a ‘mysterious’ and ‘emerging’ threat in the prestigious scientific journal The Lancet (1). In July, authorities in Brazil reported the deaths of two adults from Oropouche fever as a result […]
Read More
Death from encephalitis podcast
7 August 2024
In a recent podcast, Dr Ava Easton, CEO of Encephalitis International, and Prof Arun Venkatesan, Director of the Johns Hopkins Encephalitis Center, tackle a challenging aspect of encephalitis: mortality. This topic resonates deeply with many who have lost loved ones to this condition and addresses a reality that is often difficult to talk about yet […]
Read More
Intersectoral Global Action Plan (IGAP) is unveiled by the WHO
11 July 2024
The World Health Organization has published a new toolkit to address neurological disorders called the Intersectoral Global Action Plan (IGAP). Introduction The world of neurology just got a boost. The Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP) 2022-2031 is a resource that was created to address the significant global burden of […]
Read More
Mapping the brain
25 June 2024
Scientists have created a brain ‘atlas’ for medical research Introduction In a momentous scientific achievement, an international team of researchers working with the BRAIN Initiative Cell Census Network (BICCN) have created the most detailed maps of the human brain ever made. This ‘brain atlas’ offers a 3D view of our most complex organ and identifies […]
Read More
Encephalitis vs. encephalopathy
22 March 2024
Encephalitis and encephalopathy are acute brain conditions which may lead to acquired brain injury or death. The similarity between these words can be traced back to the ancient Greek ‘encephalo’ which means ‘pertaining to the brain’. However, there are some key differences. Encephalitis is an inflammation or swelling of the brain, usually caused by viral […]
Read More
£2.3m study to investigate COVID-19 effects
8 December 2023
A grant worth £2.3 million pounds has been awarded to clinical researchers from the University of Liverpool and King’s College London to investigate the neurological and neuropsychiatric effects of COVID-19. The COVID-19 Clinical Neuroscience Study (COVID-CNS) will look at 800 UK patients who were admitted to hospital with COVID-19 and had neurological or neuropsychiatric […]
Read More
Seven-year HSV encephalitis study nears the finishing line
23 November 2023
Researchers are entering the final stages of a seven-year study which they hope will revolutionise the treatment of patients with Herpes Simplex Virus (HSV) encephalitis. The DexEnceph study recently recruited its final patient since December 2015 with the research team now working to complete the follow up and analyse their findings in time for the Encephalitis Conference in […]
Read More
Research: monkeypox linked to encephalitis in some patients
23 November 2023
Monkeypox linked to encephalitis or confusion in some patients Monkeypox can sometimes lead to neurological complications such as encephalitis, confusion or seizures, finds a new review of evidence. Several studies incorporated in the systematic review and meta-analysis of evidence, published in eClinicalMedicine, also found that muscle aches, fatigue, headache, anxiety and depression were all relatively […]
Read More
Enceph-IG Trial - care centres needed
12 September 2023
Enceph-IG Trial: Intravenous Immunoglobulin (IVIG) in Autoimmune Encephalitis in Adults –A Randomised Double-Blind Placebo-Controlled Trial Can you help? Researchers are seeking secondary or tertiary care centres to help a trial establish whether with intravenous immunoglobulin improves recovery in adults with autoimmune encephalitis. Enceph-IG is a phase III, double blind, randomised placebo control trial lead by […]
Read More